AMENDMENT #3 TO PROJECT RIDER #1 COLLABORATION AGREEMENTProject Rider • March 3rd, 2021 • Magenta Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 3rd, 2021 Company IndustryThis Amendment #3 to Project Rider #1 (“Amendment #3”) is entered into effective as of the date of the final signature executing this Amendment #3 (“Amendment #3 Effective Date”) by and between Magenta Therapeutics, Inc. (“Magenta”) and National Marrow Donor Program d/b/a Be The Match Biotherapies (“BTMB”) (each a “Party” and collectively the “Parties”).